Olema Pharmaceuticals, Inc.
OLMA
$13.59
-$0.23-1.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -43.65% | -25.47% | -22.24% | -29.80% | -29.75% |
| Total Depreciation and Amortization | 11.09% | 24.68% | 14.79% | 30.83% | 18.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.82% | -19.89% | 8.26% | 19.67% | 28.54% |
| Change in Net Operating Assets | 244.61% | -69.72% | -93.64% | -101.56% | -4,802.42% |
| Cash from Operations | -19.14% | -40.60% | -39.50% | -37.81% | -43.76% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 96.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.39% | -66.83% | -995.56% | 2.31% | -90.32% |
| Cash from Investing | 10.40% | -66.54% | -978.17% | 2.48% | -89.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.25% | -17.26% | 909.56% | 61.87% | 87.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.16% | -194.48% | -17,683.78% | -7,738.55% | -3,822.89% |
| Cash from Financing | -1.32% | -21.40% | 866.59% | 55.61% | 83.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.73% | -228.53% | 99.23% | 296.95% | 335.07% |